Prothena Corporation plc is a clinical-stage biotechnology company based in Dublin, Ireland, focused on the discovery and development of innovative therapies for severe, life-threatening diseases. With a robust pipeline aimed at addressing disorders linked to protein misfolding, including Alzheimer's disease and other neurodegenerative conditions, Prothena is dedicated to meeting substantial unmet medical needs. Leveraging state-of-the-art scientific research and a strong portfolio of intellectual property, the company is strategically positioned to be a leader in the biopharmaceutical industry, driving advancements that could significantly impact patient outcomes worldwide.